(Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Turnover | -45.78%13.93B | -47.41%9.52B | -46.41%5.06B | -20.69%32.81B | -6.99%25.68B | 26.47%18.11B | 75.91%9.44B | 274.63%41.37B | 291.45%27.61B | 255.80%14.32B |
Operating income | -45.78%13.93B | -47.41%9.52B | -46.41%5.06B | -20.69%32.81B | -6.99%25.68B | 26.47%18.11B | 75.91%9.44B | 274.63%41.37B | 291.45%27.61B | 255.80%14.32B |
Cost of sales | ---- | 39.56%-8.46B | ---- | -34.26%-28.2B | ---- | -147.24%-14B | ---- | -214.18%-21.01B | ---- | -116.17%-5.66B |
Operating expenses | 41.21%-12.48B | 39.56%-8.46B | 19.78%-4.74B | -34.26%-28.2B | -74.45%-21.23B | -147.24%-14B | -230.59%-5.92B | -214.18%-21.01B | -167.74%-12.17B | -116.17%-5.66B |
Gross profit | -67.61%1.44B | -74.15%1.06B | -91.12%313.03M | -77.37%4.61B | -71.19%4.45B | -52.52%4.11B | -1.48%3.52B | 367.39%20.36B | 515.75%15.44B | 516.08%8.66B |
Selling expenses | -34.74%-102.61M | -38.20%-68.4M | -42.02%-42.49M | -51.19%-177.44M | -8.96%-76.15M | -21.89%-49.49M | -158.47%-29.92M | -90.45%-117.36M | -84.60%-69.89M | -69.74%-40.6M |
Administrative expenses | -26.92%-831.26M | -1.61%-1.08B | -102.27%-304.85M | -16.78%-2.34B | -28.31%-654.98M | -16.51%-1.06B | 31.23%-150.72M | -137.96%-2B | -79.88%-510.48M | -332.53%-912.27M |
Research and development expenses | 27.26%-684.98M | ---- | 44.67%-216.84M | ---- | 1.13%-941.62M | ---- | -84.99%-391.93M | ---- | -373.80%-952.43M | ---- |
Profit from asset sales | -102.50%-34.64K | ---- | -81.59%-24.67K | ---- | -65.30%1.39M | ---- | ---13.59K | ---- | 1,776.76%3.99M | ---- |
Revaluation surplus | -187.70%-570.47M | ---- | -274.78%-268.86M | ---- | 24.76%650.52M | ---- | -67.56%153.83M | ---- | -47.53%521.44M | ---- |
-Changes in the fair value of other assets | -187.70%-570.47M | ---- | -274.78%-268.86M | ---- | 24.76%650.52M | ---- | -67.56%153.83M | ---- | -47.53%521.44M | ---- |
Impairment and provision | 69.67%-306.43M | ---- | 91.88%-97.62M | ---- | -2,471.08%-1.01B | ---- | -1,222,994.39%-1.2B | ---- | -221.98%-39.29M | ---- |
-Other impairment is provision | 69.67%-306.43M | ---- | 91.88%-97.62M | ---- | -2,471.08%-1.01B | ---- | -1,222,994.39%-1.2B | ---- | -221.98%-39.29M | ---- |
Operating interest expense | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -36.24%-194.71M |
Special items of operating profit | -83.45%712.82M | -156.31%-763.44M | -42.92%345.73M | 2.80%1.05B | 47.26%4.31B | 318.50%1.36B | 29.45%605.69M | -59.32%1.02B | 5,744.98%2.93B | -197.39%-620.54M |
Operating profit | -106.15%-410.39M | -119.50%-849.13M | -111.65%-290.34M | -83.66%3.15B | -61.01%6.67B | -36.80%4.35B | -38.31%2.49B | 237.56%19.27B | 475.71%17.11B | 313.87%6.89B |
Financing cost | -38.77%-526.8M | -47.93%-506.78M | -50.48%-209.41M | -92.55%-784.31M | -477.51%-379.61M | ---342.58M | -251.25%-139.16M | ---407.33M | 167.67%100.56M | ---- |
Share of profits of associates | ---- | -74.74%156.7M | ---- | -44.83%923.76M | ---- | 0.30%620.29M | ---- | 2,401.34%1.67B | ---- | 1,582.72%618.43M |
Share of profit from joint venture company | ---- | -87.96%194.94M | ---- | -10.47%2.01B | ---- | 78.07%1.62B | ---- | 42,985.18%2.24B | ---- | 1,536.91%909.21M |
Special items of earning before tax | -104.64%-2.07M | ---- | 83.37%-35.12K | ---- | 78.19%44.6M | ---- | -100.66%-211.19K | ---- | 451.86%25.03M | ---- |
Earning before tax | -114.83%-939.26M | -116.07%-1B | -121.23%-499.78M | -76.76%5.29B | -63.24%6.34B | -25.74%6.25B | -41.64%2.35B | 294.71%22.78B | 512.00%17.23B | 413.83%8.42B |
Tax | 79.64%-92.83M | 83.98%-60.52M | 49.48%-95.87M | 70.52%-683.47M | 79.70%-455.97M | 64.57%-377.64M | 59.91%-189.78M | -549.34%-2.32B | -718.81%-2.25B | -502.34%-1.07B |
After-tax profit from continuing operations | -117.55%-1.03B | -118.13%-1.06B | -127.53%-595.65M | -77.46%4.61B | -60.77%5.88B | -20.11%5.87B | -39.21%2.16B | 277.92%20.46B | 489.68%14.99B | 403.11%7.35B |
Earning after tax | -117.55%-1.03B | -118.13%-1.06B | -127.53%-595.65M | -77.46%4.61B | -60.77%5.88B | -20.11%5.87B | -39.21%2.16B | 277.92%20.46B | 489.68%14.99B | 403.11%7.35B |
Minority profit | -200.50%-391.7M | -8,806.21%-305.66M | 32.62%-156.75M | -765.08%-371.56M | -167.78%-130.35M | -103.55%-3.43M | -765.72%-232.63M | -122.83%-42.95M | 179.56%192.32M | 110.08%96.74M |
Profit attributable to shareholders | -110.66%-640.39M | -112.92%-759.14M | -118.31%-438.9M | -75.70%4.98B | -59.38%6.01B | -19.00%5.88B | -32.01%2.4B | 292.35%20.5B | 498.31%14.79B | 412.65%7.25B |
Basic earnings per share | -110.74%-0.32 | -113.01%-0.38 | -118.49%-0.22 | -75.74%2.47 | -59.46%2.98 | -18.89%2.92 | -32.00%1.19 | 281.27%10.18 | 315.25%7.35 | 386.49%3.6 |
Diluted earnings per share | -110.74%-0.32 | -113.01%-0.38 | -118.49%-0.22 | -75.71%2.47 | -59.35%2.98 | -18.89%2.92 | -32.00%1.19 | 282.33%10.17 | 314.12%7.33 | 386.49%3.6 |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | CAS (2007) | IAS | CAS (2007) | IAS | CAS (2007) | IAS | CAS (2007) | IAS | CAS (2007) | IAS |
Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- |
Auditor | -- | -- | -- | Ernst & Young Huaming Certified Public Accountants (Special General Partnership) | -- | -- | -- | Ernst & Young Huaming Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data
No Data